Roivant Sciences (ROIV) Debt to Equity (2021 - 2024)
Historic Debt to Equity for Roivant Sciences (ROIV) over the last 4 years, with Q2 2024 value amounting to $0.03.
- Roivant Sciences' Debt to Equity fell 7773.62% to $0.03 in Q2 2024 from the same period last year, while for Jun 2024 it was $0.03, marking a year-over-year decrease of 7773.62%. This contributed to the annual value of $0.03 for FY2024, which is 7506.69% down from last year.
- Latest data reveals that Roivant Sciences reported Debt to Equity of $0.03 as of Q2 2024, which was down 7773.62% from $0.03 recorded in Q1 2024.
- Roivant Sciences' Debt to Equity's 5-year high stood at $0.16 during Q3 2023, with a 5-year trough of $0.02 in Q1 2022.
- For the 4-year period, Roivant Sciences' Debt to Equity averaged around $0.08, with its median value being $0.09 (2021).
- As far as peak fluctuations go, Roivant Sciences' Debt to Equity plummeted by 8083.5% in 2022, and later skyrocketed by 71736.47% in 2023.
- Roivant Sciences' Debt to Equity (Quarter) stood at $0.09 in 2021, then soared by 50.56% to $0.14 in 2022, then tumbled by 75.81% to $0.03 in 2023, then grew by 4.42% to $0.03 in 2024.
- Its Debt to Equity stands at $0.03 for Q2 2024, versus $0.03 for Q1 2024 and $0.03 for Q4 2023.